High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$146M
$146,700,044
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-04
$390,825x3
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-04 | $390,825x3 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-02 | $140,431x4 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
HENDERSON MICHAEL THOMAS
• CEO
10b5-1 Sell
2026-02-11
$1,266,953Largex3
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-11 | $1,266,953Largex3 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-04
$361,860x5
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-04 | $361,860x5 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-02-02 | $131,630x3 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Fairmount Funds Management LLC
• Director
Discretionary SellΔOwn -85.4%
2026-01-22
$133,525,000MEGA
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Director
Discretionary SellΔOwn -85.4%
|
2026-01-22 | $133,525,000MEGA | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
HENDERSON MICHAEL THOMAS
• CEO
10b5-1 Sell
2026-01-14
$1,622,159Largex6
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-14 | $1,622,159Largex6 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-01-07
$1,455,613Largex4
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-01-07 | $1,455,613Largex4 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-12-19 | $120,000 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
HENDERSON MICHAEL THOMAS
• CEO
10b5-1 Sell
2025-12-10
$1,507,657Largex3
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-10 | $1,507,657Largex3 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-04
$817,500
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-04 | $817,500 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-12-04 | $112,500 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
HENDERSON MICHAEL THOMAS
• CEO
10b5-1 Sell
2025-12-04
$3,000,400Large
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $3,000,400Large | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-11-14 | $130,000 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
HENDERSON MICHAEL THOMAS
• CEO
10b5-1 Sell
2025-11-13
$1,260,236Largex4
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-13 | $1,260,236Largex4 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-11-11 | $60,000 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2025-11-05
$593,903x4
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-11-05 | $593,903x4 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-01
$203,378
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-01 | $203,378 | S | Form 4 |